{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:11:34Z","timestamp":1794211894873,"version":"4.8.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Despite the benefits of home treatment with outpatient parenteral antimicrobial therapy (OPAT), children with pyelonephritis and meningitis are rarely included. We aimed to compare clinical characteristics and outcomes between hospital and home treatment for these conditions and to identify factors influencing home treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children admitted to the hospital with pyelonephritis or proven and presumed bacterial meningitis from January 1, 2012, to December 31, 2013 were identified retrospectively. Patients who received any OPAT (home group) received daily visits via our Hospital-in-the-Home (HITH) program; inpatients (hospital group) received standard care. Clinical and demographic features, length of stay, readmission rate and cost were compared between hospital and home groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred thirty-nine children with pyelonephritis and 70 with meningitis were identified, of which 127 and 44 were potentially suitable for OPAT, respectively. Of these, 12 (9%) with pyelonephritis received OPAT, contrasting with 29 (66%) with meningitis. Clinical features did not differ between hospital- and home-treated patients for either condition. Patients with meningitis in the hospital group were younger than those transferred to HITH (1 vs. 2 months; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). All patients were afebrile before transfer to HITH. Admissions for pyelonephritis were brief with inpatients having a shorter length of stay than home patients (median: 3 vs. 4.5 days; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002). Unplanned readmission rates were comparable across all groups. Transfer to HITH resulted in a saving of AU$178,180.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Children with pyelonephritis and meningitis can feasibly receive OPAT. Age, treatment duration and fever influence this decision. None of these should be barriers to OPAT, and the cost savings support change in practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001605","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T15:38:46Z","timestamp":1491925126000},"page":"827-832","source":"Crossref","is-referenced-by-count":20,"title":["A Comparison of Hospital Versus Outpatient Parenteral Antibiotic Therapy at Home for Pyelonephritis and Meningitis"],"prefix":"10.1097","volume":"36","author":[{"given":"Conor C.","family":"Hensey","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sett","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Connell","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope A.","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dku401","article-title":"Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement.","volume":"70","author":"Patel","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/pch\/16.2.105","article-title":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Home intravenous therapy: accessibility for Canadian children and youth. Position statements and practice points.","volume":"16","author":"Moore","year":"2011","journal-title":"Paediatr Child Health"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yapd.2010.09.002","article-title":"Pediatric outpatient parenteral antimicrobial therapy: an update.","volume":"57","author":"Maraqa","year":"2010","journal-title":"Adv Pediatr"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-1754.2007.01236.x","article-title":"Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre.","volume":"44","author":"Gouin","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1542\/peds.2004-0421","article-title":"Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.","volume":"114","author":"Gauthier","year":"2004","journal-title":"Pediatrics"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PEC.0b013e318248b19b","article-title":"Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis.","volume":"28","author":"Brugha","year":"2012","journal-title":"Pediatr Emerg Care"},{"key":"R7-20230912","first-page":"CD000356","article-title":"Hospital at home early discharge.","author":"Shepperd","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5694\/mja12.10480","article-title":"A meta-analysis of \u201chospital in the home\u201d.","volume":"197","author":"Caplan","year":"2012","journal-title":"Med J Aust"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.5694\/j.1326-5377.2010.tb04070.x","article-title":"The 500-bed hospital that isn\u2019t there: the Victorian Department of Health review of the Hospital in the Home program.","volume":"193","author":"Montalto","year":"2010","journal-title":"Med J Aust"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1071\/AH09771","article-title":"Medically-managed hospital in the home: 7 year study of mortality and unplanned interruption.","volume":"34","author":"Montalto","year":"2010","journal-title":"Aust Health Rev"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/j.1326-5377.2002.tb04450.x","article-title":"5: hospital-in-the-home treatment of infectious diseases.","volume":"176","author":"Howden","year":"2002","journal-title":"Med J Aust"},{"key":"R13-20230912","first-page":"CD004383","article-title":"Specialist home-based nursing services for children with acute and chronic illnesses.","author":"Parab","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pbc.24474","article-title":"Hospital-based home care for children with cancer: feasibility and psychosocial impact on children and their families.","volume":"60","author":"Hansson","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/adc.87.5.371","article-title":"Randomised controlled trial comparing an acute paediatric hospital at home scheme with conventional hospital care.","volume":"87","author":"Sartain","year":"2002","journal-title":"Arch Dis Child"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/adc.87.6.489","article-title":"Economic evaluation of an acute paediatric hospital at home clinical trial.","volume":"87","author":"Bagust","year":"2002","journal-title":"Arch Dis Child"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/adc.2008.144709","article-title":"Home oxygen for children with acute bronchiolitis.","volume":"94","author":"Tie","year":"2009","journal-title":"Arch Dis Child"},{"key":"R18-20230912","first-page":"110","article-title":"Outpatient parenteral antimicrobial therapy: a report of three years experience.","volume":"107","author":"Glackin","year":"2014","journal-title":"Ir Med J"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/01241398-200207000-00017","article-title":"Outpatient parenteral antimicrobial therapy in osteoarticular infections in children.","volume":"22","author":"Maraqa","year":"2002","journal-title":"J Pediatr Orthop"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00006454-200105000-00015","article-title":"Complications of outpatient parenteral antibiotic therapy in childhood.","volume":"20","author":"Gomez","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1542\/peds.2005-1465","article-title":"Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis.","volume":"117","author":"Ruebner","year":"2006","journal-title":"Pediatrics"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/313503","article-title":"Outpatient parenteral antimicrobial therapy for central nervous system infections.","volume":"29","author":"Tice","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/INF.0b013e31827ee1c2","article-title":"Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children\u2019s hospital.","volume":"32","author":"Madigan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/peds.2008-2583","article-title":"Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics.","volume":"124","author":"Dor\u00e9-Bergeron","year":"2009","journal-title":"Pediatrics"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/INF.0000000000000992","article-title":"Who can have parenteral antibiotics at home?: a prospective observational study in children with moderate\/severe cellulitis.","volume":"35","author":"Ibrahim","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/archdischild-2015-309731","article-title":"The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.","volume":"101","author":"Hodgson","year":"2016","journal-title":"Arch Dis Child"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R30-20230912","first-page":"CD003772","article-title":"Antibiotics for acute pyelonephritis in children.","author":"Strohmeier","year":"2014","journal-title":"Cochrane Database of Syst Rev"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.2011-0814","article-title":"Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children.","volume":"129","author":"Bocquet","year":"2012","journal-title":"Pediatrics"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00431-007-0638-1","article-title":"Randomised trial of oral versus sequential intravenous\/oral cephalosporins in children with pyelonephritis.","volume":"167","author":"Neuhaus","year":"2008","journal-title":"Eur J Pediatr"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","article-title":"Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial.","volume":"335","author":"Montini","year":"2007","journal-title":"BMJ"},{"issue":"1 pt 1","key":"R34-20230912","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children.","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006454-198803000-00005","article-title":"Outpatient therapy of serious pediatric infections with ceftriaxone.","volume":"7","author":"Bradley","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-3476(87)80406-7","article-title":"Outpatient treatment of serious infections in infants and children with ceftriaxone.","volume":"110","author":"Powell","year":"1987","journal-title":"J Pediatr"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756285609337975","article-title":"Pathophysiology and treatment of bacterial meningitis.","volume":"2","author":"Hoffman","year":"2009","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201709000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:01:10Z","timestamp":1694559670000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201709000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001605","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}